Stockscreener 앱 받기
0.3876
7.27%
-0.0304
Protagenic Therapeutics Inc 주식(PTIX)의 최신 뉴스
Protagenic Therapeutics, Inc.\new SEC 10-K Report - TradingView
PTIX stock plunges to 52-week low, hitting $0.23 - Investing.com India
PTIX stock plunges to 52-week low, hitting $0.23 By Investing.com - Investing.com Australia
Protagenic Therapeutics (NASDAQ:PTIX) Stock Price Down 6.5% – Here’s Why - Defense World
BDSX Shrinks Loss With Revenue Growth, ALLR Plans $5Mln Share Buyback, What's The Buzz At PTIX? - RTTNews
PTIX stock plunges to 52-week low, hitting $0.25 By Investing.com - Investing.com Canada
Protagenic Therapeutics adjusts stock option prices By Investing.com - Investing.com South Africa
Protagenic Therapeutics adjusts stock option prices - Investing.com India
Protagenic Therapeutics Reprices Stock Options at Annual Meeting - TipRanks
Protagenic Therapeutics to Present at the B. Riley Securities Neuro and Ophthalmology Virtual Investor Conference on April 27th - ACCESS Newswire
PTIX stock touches 52-week low at $0.25 amid sharp annual decline - MSN
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
PTIX’s Market Whiplash: -23.55% YTD Decline, -25.97% Plunge in 30 Days - The InvestChronicle
Stock Market Recap: Protagenic Therapeutics Inc (PTIX) Concludes at 0.37, a 11.82 Surge/Decline - The Dwinnex
Why Coherent Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket - Benzinga
Protagenic Therapeutics Inc (PTIX) Shares Plummet Below 1-Year High - The News Heater
Protagenic Therapeutics, Inc. (NASDAQ:PTIX) Sees Significant Decrease in Short Interest - Defense World
Protagenic Therapeutics Announces Resolution of Nasdaq Deficiency Notice - ACCESS Newswire
Protagenic Therapeutics Reports Fourth Quarter and Full Year 2023 Results - ACCESS Newswire
Protagenic Therapeutics Announces Date of Annual Shareholder Meeting - ACCESS Newswire
Protagenic Therapeutics Announces Closing of Private Placement for Aggregate Gross Proceeds of $1.275 Million - ACCESS Newswire
Protagenic Therapeutics to Effect 1-for-4 Reverse Stock Split - ACCESS Newswire
Performance Tech Stock Hits 52-Week Low at $0.44 Amid Market Challenges - Investing.com
Protagenic Therapeutics, Inc. Enters into Amendment No. 1 to At Market Issuance Sales Agreement - Defense World
Protagenic Therapeutics Inc’s (PTIX) -12.44% Retreat Justifies A Second Look - Stocks Register
PTIX stock touches 52-week low at $0.45 amid market challenges - Investing.com Nigeria
Pre-market Movers: EWTX, TNXP, LNSR, VRDN... - RTTNews
Protagenic Therapeutics (NASDAQ:PTIX) Faces Delisting Threat from NasdaqUnited States Securities and Exchange CommissionWashington, D.C. 20549FORM 8-KCURRENT REPORTPursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934D - Defense World
Protagenic Therapeutics faces Nasdaq delisting over equity deficit - Investing.com
PTIX stock touches 52-week low at $0.48 amid market challenges - Investing.com India
Galapagos NV (GLPG) Stock Surges Amid Strong Industry Performanc - GuruFocus.com
Protagenic Therapeutics Receives Delist Determination Letter from Nasdaq - Defense World
Protagenic Therapeutics faces Nasdaq delisting over equity shortfall - Investing.com India
Protagenic Therapeutics faces Nasdaq delisting over equity shortfall By Investing.com - Investing.com Australia
ARMISTICE CAPITAL, LLC Acquires New Stake in Protagenic Therapeu - GuruFocus.com
Protagenic Therapeutics Inc. Warrant (PTIXW) Quarterly 10-Q Report - Quartz
Protagenic Therapeutics Inc. (PTIX) Quarterly 10-Q Report - Quartzy
Protagenic Therapeutics Completes Private Placement, Raises $1.275 Million - Defense World
Protagenic Therapeutics Raises $1.27M in Private Placement with Warrant Offerings | PTIX Stock News - StockTitan
Protagenic Therapeutics Raises $1.275M for Growth Initiatives - TipRanks
Protagenic Therapeutics Secures $1.275M in Private Placement - TipRanks
Protagenic Therapeutics announces $1.275 million stock sale By Investing.com - Investing.com Canada
Protagenic Therapeutics announces $1.275 million stock sale - Investing.com
Protagenic Therapeutics to sell 1.95M shares at 64c in private placement - TipRanks
Protagenic Therapeutics Announces Pricing of Private Placement for Aggregate Gross Proceeds of $1.275 Million - AccessWire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
PTIX stock touches 52-week low at $0.49 amid market challenges By Investing.com - Investing.com South Africa
PTIX stock touches 52-week low at $0.49 amid market challenges - Investing.com Canada
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
3.01%
자본화:
|
볼륨(24시간):